Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Machine learning for the prediction of post-ERCP pancreatitis risk: A proof-of-concept study
Livia Archibugi1, Gianmarco Ciarfaglia1, Karina Cárdenas-Jaén2
1Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.
Machine learning models can predict Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis (PEP) risk more accurately than traditional methods. Gradient boosting models identified key predictive features, improving patient management strategies.
Area of Science:
- Medical informatics
- Gastroenterology
- Machine learning in healthcare
Background:
- Predicting Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis (PEP) is crucial for patient management.
- Previous studies using standard statistical methods have limited accuracy in identifying PEP risk factors.
Purpose of the Study:
- To develop and evaluate machine learning (ML) models for predicting PEP probability.
- To identify significant clinical features associated with PEP risk.
Main Methods:
- An international, multicenter, prospective cohort of ERCP patients was analyzed.
- Gradient boosting (GB) and logistic regression (LR) models were trained and tested.
- SHAP (Shapley Additive exPlanations) was used to interpret model features.
Main Results:
- The GB model demonstrated superior performance with an Area Under Curve (AUC) of 0.671 in the test set, outperforming LR.
- Key predictors for PEP included bilirubin levels, age, BMI, procedure duration, and previous procedures.
- Several pre-procedural factors were identified as significant contributors to PEP risk.
Conclusions:
- Gradient boosting models significantly outperform logistic regression for PEP prediction.
- ML models can identify novel and existing clinical features relevant to PEP risk.
- These findings can aid in refining patient selection and procedural strategies to mitigate PEP.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Endoscopic Procedures V: ERCP
Patient...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include: